Fullido, Fairi Shyn .

HRN: 20-36-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/16/2023
06/23/2023
IV
995mg
Q6
PCAP D
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: